DENTSPLY SIRONA Inc.

NASDAQ:XRAY

Medical - Instruments & Supplies

Healthcare
$8.52 +1.84%

+$0.19 today

Market cap
$1.70B
Beta
0.91
P/E (TTM)
-3.3
EPS (TTM)
-$3.14
Dividend yield
6.27%
52W Low $9.41High $17.09

Volume 5.40M

Average 4.70M

XRAY Operating Cash Flow

Cash generated by the company's core business operations during the period.

DENTSPLY SIRONA Inc.NASDAQ: XRAY

Operating Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Operating cash flow growth accelerates

Q1 FY2026 operating cash flow of $40M rose 471.4% year over year, ahead of the -39.5% change in trailing-twelve-month operating cash flow. Sequentially, it fell 60.4% from the prior quarter. Over 3 fiscal years it compounded at -23.1% a year.

Context

  • Operating cash flow amounted to 6.4% of revenue in FY2025, down 5.8 pp from a year earlier.
  • Operating cash flow increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +471.4% holds above the trailing-twelve-month pace of -39.5%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$40M-60.4% QoQ
Last fiscal yearDec 2025
$235M-49.0% YoY
LTMMar 2026
$268M-39.5% YoY
Operating Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+471.4%——
1 year-49.0%——
3-year CAGR-23.1%——
5-year CAGR——
10-year CAGR——

Operating Cash Flow history

USD · from the cash flow

Latest · FY2025
235M USD
Year-over-year change
-49.0%
4-year CAGR
-22.7%

Operating Cash Flow vs competitors

How XRAY compares with its peers on the latest reported figures

  • XRAY's LTM Mar 2026 operating cash flow of $268M is the smallest of the 4 companies compared; the peer median is $700M.
  • Its year-over-year change of -39.5% is the lowest of 4, against a peer median of +3.4%.
  • Operating cash flow amounts to 7.3% of revenue for XRAY, versus a peer median of 10.5%.
XRAY Competitors Peer median
Operating Cash Flow for XRAY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALGNAlign Technology, Inc.LTM Jun 2026$755.7M +3.4%+1.4%18.3%
HSICHenry Schein, Inc.LTM Jun 2026$700M +36.7%+5.8%5.1%
NVSTEnvista Holdings CorpLTM Oct 2026$301.8M +0.6%+14.7%10.5%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026$268M -39.5%-23.1%7.3%
Peer median (excluding XRAY) $700M+3.4%+5.8%10.5%

Competitors are the stored peer set for XRAY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income411M(950M)(132M)(910M)(598M)
Depreciation & Amortization346M328M343M349M352M
Deferred Income Tax(25M)(228M)(130M)(136M)30M
Stock-Based Compensation48M59M46M39M33M
Change in Working Capital(126M)(78M)(89M)95M(222M)
Accounts Receivables(117M)85M(58M)104M(91M)
Inventory(64M)(141M)6M17M(17M)
Accounts Payables(49M)30M14M(30M)11M
Other Working Capital104M(52M)(51M)4M(125M)
Other Non-Cash Items3M1.39B339M1.02B640M
Operating Cash Flow657M517M377M461M235M
Capital Expenditures(142M)(149M)(149M)(180M)(131M)
Acquisitions (Net)(220M)013M00
Purchases of Investments00000
Sales of Investments2M13M000
Other Investing Activities2M(2M)47M(17M)(1M)
Investing Cash Flow(358M)(138M)(89M)(197M)(132M)
Debt Repayment(102M)(60M)119M90M54M
Common Stock Issued00000
Common Stock Repurchased(200M)(150M)(300M)(250M)0
Dividends Paid(92M)(104M)(116M)(126M)(128M)
Other Financing Activities15M(15M)(10M)(16M)(6M)
Financing Cash Flow(379M)(329M)(307M)(302M)(80M)
Effect of Forex Changes(19M)(24M)(12M)(24M)31M
Net Change in Cash(99M)26M(31M)(62M)54M
Free Cash Flow515M368M228M281M104M

DENTSPLY SIRONA Inc.

NASDAQ:XRAY

Intrinsic Alpha fair value

Locked

Current Price

$8.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.